CSPC Innovation Pharmaceutical’s HK IPO Application Lapses, World’s Largest Synthetic Caffeine Producer
NewTimeSpaceNews: As shown on the official website of the Hong Kong Stock Exchange, the Main Board listing application filed by CSPC Innovation Pharmaceutical Co., Ltd. on December 10, 2025 has lapsed after six months. CITIC Securities served as the sole sponsor at the time of submission.
CSPC Innovation Pharmaceutical has long been engaged in the big health sector. Founded in 2006, it has focused on the R&D and production of caffeine. The company has maintained its position as the world’s largest chemical synthetic caffeine manufacturer from 2020 to 2024, supplying caffeine globally to international giants including Coca-Cola, PepsiCo and Red Bull. In 2024, it acquired control of Giant Biotech, expanding its core business into biopharmaceuticals. The company has built strong technological capabilities in antibody drugs, ADCs and mRNA vaccines, with 15 drug candidates in clinical or late-stage development.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CSPC Innovation Refiles HKEX Listing Application, World’s Largest Producer of Synthetic Caffeine
- CSOP FTSE HK Equity(03443.HK) up 0.51%, MPF assets seen ~HK$1.705tn
- iShares India(02836.HK) up 0.59%, FII outflow Rs185.3bn in Sept
- CSOP Nikkei 2x Short(07515.HK) up 0.74%, 10-yr JGB yield at 30-yr high
- Tracker(02800.HK) up 0.80%, Deloitte sees HK FY IPO proceeds ≥HK$480bn
